Pharmacological Treatment of Early Multiple Sclerosis

Author： Stüve Olaf   Bennett Jeffrey L.   Hemmer Bernhard  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.68, Iss.1, 2008-01, pp. : 73-83

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological methods to overcome IFN-β antibody formation in the treatment of multiple sclerosis

By Bagnato Francesca   Pozzilli Carlo  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 7, 2003-07 ,pp. : 1153-1163

Informa Healthcare

Access to resources Recommend Favorite

Early-Stage Multiple Sclerosis: What Are the Treatment Options?

By Per Soelberg Sorensen  

Drugs, Vol. 64, Iss. 18, 2004-01 ,pp. : 2021-2029

Adis International

Access to resources Recommend Favorite

Multiple sclerosis and its treatment

By Giovannoni Gavin   Miller David H  

Clinical Medicine, Vol. 33, Iss. 4, 1999-07 ,pp. : 315-322

Royal College Of Physicians

Access to resources Recommend Favorite

Multiple Sclerosis: Pathogenesis and Treatment

By  

Current Neuropharmacology, Vol. 9, Iss. 3, 2011-09 ,pp. : 409-416

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of Multiple Sclerosis

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 8, Iss. 3, 2009-07 ,pp. : 167-174

Bentham Science Publishers

Access to resources Recommend Favorite